0

Blonanserin

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP132810107
CAS132810-10-7
Structure
MDL NumberMFCD00893838
Molecular Weight367.50
InChI KeyXVGOZDAJGBALKS-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: ≥10 mg/mL
Assay≥98% (HPLC)
Colorwhite to off-white
Formpowder
Size5MG, 25MG
Storage Conditionsroom temp
1

Blonanserin Ameliorates Social Deficit Through dopamine-D

Saori Takeuchi, Hirotake Hida, Mizuki Uchida, Ryo Naruse, Akira Yoshimi, Shinji Kitagaki, Norio Ozaki, Yukihiro Noda

Neurochem Int. 2019 Sep;128:127-134.

PMID: 30998952

1

Blonanserin Versus Haloperidol in Japanese Patients With Schizophrenia: A Phase 3, 8-week, Double-Blind, Multicenter, Randomized Controlled Study

Philip D Harvey, Hiroshi Nakamura, Mitsukuni Murasaki

Neuropsychopharmacol Rep. 2019 Sep;39(3):173-182.

PMID: 31041855

1

Current Drug Treatments Targeting Dopamine D3 Receptor

Gian Marco Leggio, Claudio Bucolo, Chiara Bianca Maria Platania, Salvatore Salomone, Filippo Drago

Pharmacol Ther. 2016 Sep;165:164-77.

PMID: 27343365

1

Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials

Taro Kishi, Yuki Matsui, Yuki Matsuda, Asuka Katsuki, Hikaru Hori, Hiroko Yanagimoto, Kenji Sanada, Kiichiro Morita, Reiji Yoshimura, Yoshihisa Shoji, Katsuhiko Hagi, Nakao Iwata

Pharmacopsychiatry. 2019 Feb;52(2):52-62.

PMID: 29514360

1

Transdermal Delivery of Antipsychotics: Rationale and Current Status

Angela Abruzzo, Teresa Cerchiara, Barbara Luppi, Federica Bigucci

CNS Drugs. 2019 Sep;33(9):849-865.

PMID: 31493244

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode